The role of oxidative stress in diseases caused by mineral dusts and fibres: Current status and future of prophylaxis and treatment

Molecular and Cellular Biochemistry

Volumn 196, Issue 1-2, 1999, Pages 69-77

  Gulumian, M ^a,b  

^a National Centre for Occupational Health   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Asbestos fibres; Fibrosis; Inflammation; Mineral particles; Silica

Indexed keywords

ASBESTOS FIBER; MINERAL FIBER; SILICON DIOXIDE;

ARTICLE; ASBESTOSIS; INHALATION; LUNG FIBROSIS; MINERAL DUST; OXIDATIVE STRESS;

ANIMALS; ASBESTOSIS; BINDING SITES; DUST; HUMANS; INFLAMMATION; MINERAL FIBERS; OCCUPATIONAL DISEASES; OXIDATIVE STRESS; SILICON DIOXIDE; SURFACE PROPERTIES;

EID: 0032787719     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006918212866     Document Type: Article

References (106)

1. Stanton MF, Layard M, Tegeris A, Miller E, May M, Morgan E, Smith A: Relation of particle dimension to carcinogenicity in amphibole asbestos and other fibrous minerals. J Natl Cancer Inst 67: 965-975, 1981
2. Hochelia MF Jr: Surface chemistry, structure, and reactivity of hazardous mineral dusts. In: G.D. Guthrie Jr, B.T. Mossman (eds). Health Effects of Mineral Dusts. Reviews in Mineralogy, Vol. 28. Mineralogy Society of America, Washington, 1993, pp 275-308
3. Nash T, Allison AC, Harington JS: Physico-chemical properties of silica in relation to its toxicity. Nature 210: 259-261, 1966
4. Nolan RP, Langer AM, Harington JS, Oster G, Selikoff IJ: Quartz hemolysis as related to its surface functionalities. Environ Res 26: 503-520, 1981
5. Fubini B, Bolis V, Cavenago A, Volante M: Physico-chemical properties of crystalline silica dusts and their possible implication in various biological responses. Scan J Work Environ Health 21 (suppl 2): 9-14, 1995
6. Weitzman SA, Graceffa P: Asbestos catalyzes hydroxyl and superoxide radical generation from hydrogen peroxide. Arch Biochem Biophys 228: 373-376, 1984
7. Eberhardt MK, Romàn-Franco AA, Quiles MR: Asbestos- induced decomposition of hydrogen peroxide. Environ Res 37: 287-292, 1985
8. Gulumian M, van Wyk JA: Hydroxyl radical production in the presence of fibres by a Fenton-type reaction. Chem-Biol Interact 62: 89-97,1987
9. Vallyathan V, Mega J F, Shi X, Dalal NS: Enhanced generation of free radicals from phagocytes induced by mineral dusts. Am J Resp Cell Mol Biol 6: 404-413, 1992
10. Hatch GE, Gardner DE, Menzel DB: Stimulation of oxidant production in alveolar macrophages by pollutant and latex particles. Environ Res 23: 121-136, 1980
11. Berg I, Schlüter T, Gercken G: Increase of bovine alveolar macrophage superoxide anion and hydrogen peroxide release by dusts of different origin. J Toxicol Environ Health 39: 341-354, 1993
12. Ishizaki T, Yano E, Urano N, Evans PH: Crocidolite-induced reactive oxygen metabolites generation from human polymorphonuclear leukocytes. Environ Res 66: 208-216, 1994
13. -·) from alveolar macrophages exposed to asbestiform and nonfibrous particles. Cancer Res 47: 1681-1686, 1987
14. Dubois CM, Bissonnette E, Rola-Pleszczynski M: Asbestos fibres and silica particles stimulate rat alveolar macrophages to release tumor necrosis factor. Am Rev Resp Dis 139: 1257-1264, 1989
15. Heaney PJ, Banfield JA: Structure and chemistry of silica, metal oxides, and phosphates. In: G.D. Guthrie Jr, B.T. Mossman (eds). Health Effects of Mineral Dusts. Reviews in Mineralogy, Vol. 28. Mineralogy Society of America, Washington, 1993, 185-233.
16. Veblen DR, Wylie AG: Mineralogy of amphiboles and 1:1 layer silicates. In: G.D. Guthrie Jr, B.T. Mossman (eds). Health Effects of Mineral Dusts. Reviews in Mineralogy, Vol. 28. Mineralogy Society of America, Washington, 1993, 61-137
17. Hearne GR, Kolk B, Pollak H, van Wyk JA, Gulumian M: Bulk and surface modifications in detoxified crocidolite. J Inorg Biochem 50: 145-156, 1993
18. Brown GM, Donaldson K, Brown DM: Bronchoalveolar leukocyte response in experimental silicosis: Modulation by a soluble aluminum compound. Toxicol Appl Pharmacol 101: 95-105, 1989
19. Dufresne A, Sébastien P, Michaud D, Perrault G, Bégin R: Influence of aluminum treatments on pulmonary retention of quartz in sheep silicosis. Exp Lung Res 20: 157-168, 1994
20. Bégin R, Massé S, Dufresne A: Further information on aluminium inhalation in silicosis. Occup Environ Med 52: 778-780, 1995
21. Schlipköter HW, Brockhaus A: The action of polyvinyl pyridine on experimental silicosis. Dtsch Med Wochenschr 85: 920-923, 1960
22. Kaw JL, Beck EC, Bruck J: Studies of quartz cytotoxicity on peritoneal macrophages of guinea pigs pretreated with polyvinyl pyridine N-oxide. Environ Res 9: 313-320, 1975
23. Von Behren LA, Chudhary S, Rabinovich E, Shu MO, Tewari RP: Protective effect of poly-2-vinyl pyridine-N-oxide on susceptibility of silica-treated mice to experimental histoplasmosis. Infect Immun 42: 818-823, 1983
24. Jinduo Z, Jundge L, Guizhi L: Long-term follow-up observations of the therapeutic effect of PVNO on human silicosis. Zentralbl Bakteriol Hyg I Abt Orig B 178: 259-262, 1983
25. 204) on the cytopathogenic action of chrysotile asbestos in vivo and in vitro. Br J Exp Pathol 53: 652-658, 1972
26. Schlipköter HW, Brockhaus A: Die Hemmung der experimentallen Silikose durch subcutane Verabreichung von poly-vinylpyridine-N-oxyd. Klin Wochenschr 39: 1182-1189, 1961
27. Marchisio MA, Comolli R: Studio metabolico e morfologico deil'attività liticoprotettiva delia poli-2-vinil-piridina-N-ossido su macrofagi peritoneali trattati con silice. Med Lav 55: 401-410, 1964
28. Mao Y, Lambert ND, Knapton AD, Shi X, Saffiotti U: Protective effects of silanol group binding agents on quartz toxicity to rat lung alveolar cells. Appl Occup Environ Hyg 10: 1132-1137, 1995
29. Gulumian M, van Wyk A: Free radical scavenging properties of polyvinylpyridine N-oxide: A possible mechanism for its action in pneumoconiosis. 78: 124-128, 1987.
30. Emerson RJ, Davis GS: Effect of alveolar lining material-coated silica on rat alveolar macrophages. Environ Health Perspect 51: 81-84, 1983
31. Wallace WE, Vallyathan V, Keane MJ, Robinson V: In vitro biologic toxicity of native and surface modified silica and kaolin. J Toxicol Environ Health 16: 415-424, 1985
32. Schimmelpfeng J, Drosselmeyer E, Hofheinz V, Seidel A: Influence of surfactant components and exposure geometry on the effects of quartz and asbestos on alveolar macrophages. Environ Health Perspect 97: 225-231, 1992
33. Jabbour AJ, Holian A, Scheule RK: Lung lining fluid modification of asbestos bioactivity for the alveolar macrophage. Toxicol Appl Pharmacol 110: 283-294, 1991
34. Antonini JM, Reasor MJ: Effect of short-term exogenous pulmonary surfactant treatment on acute lung damage associated with the intratracheal instillation of silica. J Toxicol Environ Health 43: 85-101, 1994
35. Antonini JM, McCloud CM, Reasor MJ: Acute silica toxicity: Attenuation by amiodarone-induced pulmonary phospholipidosis. Environ Health Perspect 102: 372-378, 1994
36. Blake TL, DiMatteo M, Antonini JM, McCloud CM, Reasor MJ: Subchronic pulmonary inflammation and fibrosis induced by silica in rats are attenuated by amiodarone. Exp Lung Res 22: 113-131, 1996
37. Brown RC, Carthew P, Hoskins JA, Sara E, Simpson CF: Surface modification can affect the carcinogenicity of asbestos. Carcinogenesis 11: 1883-1885, 1990
38. Vallyathan V, Kang JH, Van Dyke K, Dalal NS, Castranova V: Response of alveolar macrophages to in vitro exposure to freshly fractured versus aged silica dust: The ability of Prosil 28, an organosilane material, to coat silica and reduce its biological reactivity. 33: 303-315, 1991
39. Wiessner JH, Mandel NS, Sohnle PG, Hasegawa A, Mandel GS: The effect of chemical modification of quartz surfaces on particulate-induced pulmonary inflammation and fibrosis in the mouse. Am Rev Resp Dis 141: 111-116, 1990
40. Evans PH, Brown RC, Poole A: Modification of the in vitro activities of amosite asbestos by surface derivatization. J Toxicol Environ Health 11:535-543, 1983
41. Zalma R, Bonneau L, Guignard J, Pezerat H, Jaurand MC: Formation of oxy radicals by oxygen reduction arising from the surface activity of asbestos. Can J Chem 65: 2338-2341, 1987
42. Zalma R, Bonneau L, Guignard J, Pezerat H: Production of hydroxyl radicals by iron solid compounds. Toxic Environ Chem 13: 171-187, 1987
43. Zalma R, Guignard J, Pezerat H: Production of radicals arising from surface activity of fibrous minerals. In: B.T. Mossman, R.O. Bégin (eds). Effects of Mineral Dusts on Cells. NATO ASI Series, Vol. H30. Springer-Verlag, Berlin Heidelberg, 1989, pp 257-264.
44. Gulumian M, van Wyk JA: Lipid peroxidation by mineral dusts and fibres: ESR studies of oxygen uptake during peroxidation of lipids in multilamellar liposomes. S Afr J Sci 87: 591-593, 1991
45. Yamano Y, Kagawa J, Hanoka T, Takahashi T, Kasai H, Tsugane S, Watanabe S: Oxidative DNA damage induced by silicain vivo. Environ Res 69: 102-107, 1995
46. Jackson JH, Schraufstatter IU, Hyslop PA, Vosbeck K, Sauerheber R, Weitzman SA, Cochrane CG: Role of oxidants in DNA damage. Hydroxyl radical mediates the synergistic DNA damaging effects of asbestos and cigarette smoke. J Clin Invest 80: 1090-1095, 1987
47. Hardy JA, Aust AE: The effect of iron binding on the ability of crocidolite asbestos to catalyze DNA single-strand breaks. Carcinogenesis 16: 319-325, 1995
48. Kupchan SM, Atland HW: Requirements for tumor-inhibitory activity among benzylisoquinoline alkaloids and related synthetic compounds. J Med Chem 16: 913-917, 1973
49. Yu XF, Zou CQ, Lim MB: Observation of the effect of tetrandrine on experimental silicosis of rats. Ecotoxicol Environ Saf 7: 306-312, 1983
50. Li Q, Xu Y, Zhow Z, Chen X, Huang X, Chen S, Zhun C: The therapeutic effect of tetrandrine on silicosis. Chin J Tuberc Resp Diseases 4: 321-328, 1981
51. Castranova V, Kang J-H, Ma JKH, Mo C-G, Malanga CJ, Moore MD, Schwegler-Berry D, Ma JYC: Effects of bisbenzylisoquinoline alkaloids on alveolar macrophages: Correlation between binding affinity, inhibitory potency, and antifibrotic potential. Toxicol Appl Pharmacol 108: 242-252, 1991
52. Ma JKH, Mo C-G, Malanga CJ, Ma JYC, Castranova V: Binding of bisbenzylisoquinoline alkaloids to phosphatidylcholine vesicles and alveolar macrophages: Relationship between binding affinity and antifibrotic potential of these drugs. Exp Lung Res 17: 1061-1077, 1991
53. Castranova V, Kang JH, Moore MD, Pailes WH, Frazer DG, Schwegler-Berry D: Inhibition of stimulant-induced activation of phagocytic cells with tetrandrine. J Leuk Biol 50: 412-422, 1991
54. Liu L, Chen N, Cai G, Li Z, Yang J, Li Y: Studies on the effects of tetrandrine on microtubules. I. Biochemical observation and electron microscopy. Ecotoxicol Environ Safety 15: 142-148, 1988
55. Chen N, Liu L, Cai G, Yang J, Li Y: Studies on the effects of tetrandrine on microtubules. II. Observations with immunofluorescence techniques. Ecotoxicol Environ Saf 15: 149-152, 1988
56. Cao ZF: Scavenging effect of tetrandrine on active oxygen radicals. Planta Med 62: 413-414, 1996
57. Shi X, Mao Y, Saffiotti U, Wang L, Rojanasakul Y, Leonard SS, Vallyathan V: Antioxidant activity of tetrandrine and its inhibition of quartz-induced lipid peroxidation. Toxicol Environ Health 46: 233-248, 1995
58. Pang L, Hoult RS: Cytotoxicity to macrophages of tetrandrine, an antisilicosis alkaloid accompanied by an overproduction of prostaglandins. Biochem Pharmacol 53: 773-782, 1997
59. 2-induced experimental silicosis. The Sixth International Meeting on the Toxicology of Natural and Man-Made Fibrous and Non-Fibrous Particles. Abstract 106. September 15-18, 1996
60. Khan SG, Shahid A, Rahman Q: Protective role of ascorbic acid against asbestos induced toxicity in rat lung. Drug Chem Toxicol 13: 249-256, 1990
61. Mironova GE: Effect of ascorbic acid on development of pneumofibrosis caused by silicon dioxide. Vopr Med Khim 37: 84-86, 1991
62. Holts G, Bresnick E: Ascorbic acid inhibits the squamous metaplasia that results from treatment of tracheal explants with asbestos or benzo[a]pyrene-coated asbestos. Cancer Lett 42: 23-28, 1988
63. Braughler JM, Pregenzer JF, Chase RL, Duncan LA, Jacobsen EJ, McCall JM: Novel 21-aminosteroids as potent inhibitors of iron-dpendent lipid peroxidation. J Biol Chem 262: 10438-10440, 1987
64. Antonini JM, van Dyke K, DiMatteo M, Reasor MJ: Attenuation of acute inflammatory effects of silica in rat lung by 21-aminosteroid, U74389G. Inflammation 19: 9-21, 1995
65. Maksimenko AV, Grigor'eva EL, Bezrukavnikova LM, Petrov AD, Tishchenko EG, Arkhipova OG, Torchilin VP: Antifibrotic effect of dextran aldehyde-modified superoxide dismutase in experimental silicosis. Byull Eksp Biol Med 112: 265-267, 1991
66. Mossman BT, Marsh JP, Sesko A, Hill S, Shatos MA, Doherty J, Petruska J, Adler KB, Hemenway D, Mickey R, Vacek P, Kagan E: Inhibition of lung injury, inflammation and interstitial pulmonary fibrosis by polyethylene glycol-conjugated catalase in a rapid inhalation model of asbestosis. Am Rev Resp Dis 141: 1266-1271, 1990
67. Mossman BT, Surinrut P, Brinton BT, Marsh P, Heintz NH, Lindau-Shepard B, Shaffer JB: Transfection of a manganese-containing superoxide dismutase gene into hamster tracheal epithelial cells ameliorates asbestos-mediated cytotoxicity. Free Rad Biol Med 21: 125-131, 1996
68. Goss GD, McBurney MW: Physiological and clinical aspects of vitamin A and its metabolites. Crit Rev Clin Lab Sci 29: 185-215, 1992
69. Prabhala RH, Garewal HS, Hicks MJ, Sampliner RE, Watson RR: The effects of 13-cis-retinoic acid and β-carotene on cellular immunity in humans. Cancer (Phila) 67: 1556-1560, 1991
70. Omenn GS, Goodman G, Thornquist M, Grizzle J, Rosenstock L, Barnhart S, Balmes J, Cherniack MG, Cullen MR, Glass A, Keogh J, Meyskens F Jr, Valanis B, Williams J Jr: The β-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: Smokers and asbestos-exposed workers. Cancer Res (suppl)54: 2038s-2043s, 1994
71. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL Jr, Valanis B, Williams JH Jr, Barnhart S, Hammar S: Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. New Engl J Med 334: 1150-1155, 1996
72. Chuwers P, Barnhart S, Blanc P, Brodkin CA, Cullen M, Kelly T, Keogh J, Omenn G, Williams J, Balmes JR: The protective effect of β-carotene and retinol on ventilatory function in an asbestos-exposed cohort. Am J Resp Crit Care Med 155: 1066-1071, 1997
73. Schiffman MH, Pickle LW, Fontham E, Zahm SH, Falk R, Mele J, Correa P, Fraumeni JF Jr: Case-control study of diet and mesothelioma in Louisiana. Cancer Res 48: 2911-2915, 1988
74. Rees DJ: A case-control study of mesothelioma in South Africa. A thesis submitted to the Faculty of Medicine, University of Cape Town, for the degree of Doctor of Philosophy. Johannesburg, 1995
75. Sahu AP: Chronic lung injury due to mineral particles: Possible prevention of their fibrogenic potential. The Sixth International Meeting on the Toxicology of Natural and Man-Made Fibrous and Non-Fibrous Particles. Abstract 107. September 15-18, 1996
76. Hoffman H, Hatherill JR, Crowley J, Harada H, Yonemaru M, Zheng H, Ishizaka A, Raffin TA: Early post-treatment with pentoxifylline or dibutyryl cAMP attenuates Escherichia coli-induced acute lung injury in guinea pigs. Am Rev Resp Dis 143: 289-293, 1991
77. O'Neil CA, Giri SN, Wang Q, Perricone MA, Hyde DM: Effects of dibutyryl cyclic adenosine monophosphate on bleomycin-induced lung toxicity in hamsters. J Appl Toxicol 12: 97-111, 1992
78. Kennedy TP, Michael JR, Hoidal JR, Hasty D, Sciuto AM, Hopkins C, Lazar R, Bysani GK, Tolley E, Gurtner GH: Dibutyryl cAMP, aminophylline, and β-adrenergic agonists protect against pulmonary edema caused by phosgene. J Appl Physiol 67: 2542-2552, 1989
79. Riva CM, Morganroth ML, Ljungman AG, Schoeneich SO, Marks RM, Todd RF III, Ward PA, Boxer LA: Iloprost inhibits neutrophil-induced lung injury and neutrophil adherence to endothelial monolayers. Am J Resp Cell Mol Biol 3: 301-309, 1990
80. Ochoa L, Waypa G, Mahoney JR Jr, Rodriguez L, Minnear FR: Contrasting effects of hypochlorous acid and hydrogen peroxide on endothelial permeability. Prevention with cAMP drugs. Am J Crit Care Med 156: 1247-1255, 1997
81. Israbian VA, Weitzman SA, Kamp DW: Dibutyryl cAMP attenuates asbestos-induced pulmonary epithelial cell cytotoxicity and decline in ATP levels. Am J Physiol 267: L518-L525, 1994
82. Morosova KI, Aronova GV, Katsnelson BA, Velichkovski BT, Genkin AM, Einichnykh LN, Privalova LI: On the defensive action of glutamate against the cytotoxicity and fibrogenicity of quartz dust. Br J Indust Med 39: 244-252, 1982
83. Morosova KI, Katsnelson BA, Rotenberg YS, Belobragina GV: A further experimental study of the antisilicotic effect of glutamate. Br J Indust Med 41: 518-525, 1984
84. Flowers ES: Metal-Micelle asbestos and treatment of asbestos and other mineral silicates to reduce their harmful properties: US Patent 4,328,197; May 4; assigned to Flow General Inc. McLean, Va., 1982
85. Gulumian M, van Wyk JA, Kolk B: Detoxified crocidolite exhibits reduced radical generation which could explain its lower toxicity: ESR and Mössbauer studies. In: BT Mossman, RO Bégin (eds). Effects of Mineral Dusts on Cells. NATO ASI Series, Vol. H30. Springer-Verlag, Berlin, Heidelberg, 1989, pp 197-204
86. Gulumian M, van Wyk JA, Hearne GR, Kolk B, Pollak H: ESR and Mössbauer studies on detoxified crocidolite: Mechanism of reduced toxicity. J Inorg Biochem 50: 133-143, 1993
87. Hahon N, Vallyathan V, Booth JA, Sepulveda MJ: In vitro biologic response to native and surface-modified asbestos. Environ Res 39: 345-355, 1986
88. Gulumian, M, Nkosibomvu ZL, Channa K, Pollak H: Can microwave radiation at high temperatures reduce the toxicity of fibrous crocidolite asbestos? Environ Health Perspect 105(suppl 5): 1041-1044, 1997
89. Kamp DW, Israbian VA, Preusen SE, Zhang CX, Weitzman SA: Asbestos causes DNA strand breaks in cultured pulmonary epithelial cells: Role of iron-catalyzed free radicals. Am J Physiol 268: L471-L480, 1995
90. Kamp DW, Israbian VA, Yeidandi AV, Panos RJ, Graceffa P, Weitzman SA: Phytic acid, an iron chelator, attenuates pulmonary inflammation and fibrosis in rats after intratracheal instillation of asbestos. Toxicol Pathol 23: 689-695, 1995
91. Weitzman SA, Weitberg AB: Asbestos-catalysed lipid peroxidation and its inhibition by desferroxamine. Biochem J 225: 259-262, 1985
92. Weitzman SA, Chester JF, Graceffa P: Binding of deferoxamine to asbestos fibers in vitro and in vivo. Carcinogenesis 9: 1643-1645, 1988
93. Chao C-C, Aust AE: Effect of long-term removal of iron from asbestos by desferrioxamine B on subsequent mobilization by other chelators and induction of DNA single-strand breaks. Archiv Biochem Biophys 308: 64-69, 1994
94. Driscoll KE, Maurer JK: Cytokine and growth factor release by alveolar macrophages: Potential biomarkers of pulmonary toxicity. Toxicol Pathol 19: 398-405, 1991
95. Williams AO, Saffiotti U: Growth factors and gene expression in silica-induced fibrogenesis and carcinogenesis. Appl Occup Environ Hyg 10: 1089-1098, 1995
96. Piguet PF, Vesin C, Grau GE, Thompson RC: Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica. Cytokine 5: 57-61, 1993
97. Henderson RF, Harkema JR, Hotchkiss JA, Boehme DS: Effect of blood leukocyte depletion on the inflammatory response of the lung to quartz. Toxicol Appl Pharmacol 109: 127-136, 1991
98. DiMatteo M, Reasor MJ: Modulation of silica-induced pulmonary toxicity by dexamethasone-containing liposomes. Toxicol Appl Pharmacol 142: 411-421, 1997
99. Liu K, Situ R, Liao J: The effect of anti basic fibroblast growth factor on the development of experimental silicosis bacillus. Chung Hua Chieh Ho Ho Hsi Tsa Chih (CYH) 18: 351-353, 1995
100. Piguet PF, Rosen H, Vesin C, Grau GE: Effective treatment of the pulmonary fibrosis elicited in mice by bleomycin or silica with anti-CD-11 antibodies. Am Rev Resp Dis 147: 435-441, 1993
101. Rosmanith J, Breining H: The reduction of quartz effect by natural anhydrite in animal experiment. Wiss Umwelt 182-188, 1988
102. Plastinina IuV, Privalova LI, Tereshin Slu, Katsnel'son BA, Kislitsina NS: Precutaneous effects of iodine inhibit the development of experimental silicosis. Med Tr Prom Ekol 7: 16-20, 1996
103. Li H, Wu Z, Zeng X, Liu S, Zheng Z, Zeng L, Duanmu B, Ke F, Yang H, Qing Y: Pathological observation of experimental asbestosis treated by hydroxypiperquin phosphate in dogs. Huaxi Yike Daxue Xuebao 22: 181-184, 1991
104. Soodaeva SK, Ostrakhovich EA, Velichkovskii BT: Changes in the blood serum antioxidant system and peroxidation of lipids during exposure to asbestos. Byull Eksp Biol Med 118: 145-147, 1994
105. Yu L, Zhou CQ, Li YR, Qu L, Xing KJ, Du QC: A biochemical study on combined treatment of experimental silicosis with tetrandrine-PVNO and tetrandrine-QOHP in rats. Biomed Environ Sci 8: 265-268, 1995
106. Muhle H, Bellmann B, Pott F: Durability of various mineral fibres in rat lungs. In: R.C. Brown, J.A. Hoskins, N.F. Johnson (eds). Mechanisms in Fibre Carcinogenesis. NATO ASI Series A. Life Sciences 223, Plenum Press, New York, 1991, pp 181-187